| Market Cap | ₹774Cr |
| ROE | 11.84% |
| P/E Ratio(TTM) | 20.01 |
| EPS(TTM) | 3.86 |
| P/B Ratio | 2.37 |
| Dividend Yield | 0.97% |
| Industry P/E | 39.81 |
| Book Value | 32.62 |
| Debt to Equity | 0.00 |
| Face Value | 5 |
| Parent Organisation | Anuh Pharma |
| Managing Director | Mr. Ritesh B. Shah |
| Founded | 1960 |
| NSE Symbol | ANUHPHR |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Divi's Laboratories | NA (0.00%) | 68.16 | ||
| Neuland Laboratories | NA (0.00%) | 84.50 | ||
| Jubilant Pharmova | NA (0.00%) | 35.37 | ||
| Acutaas Chemicals | NA (0.00%) | 59.16 |